Genky DrugStores Co., Ltd.
Financial Summary for the Second Quarter (Interim) of the Fiscal Year Ending June 2026 [Japanese Standards] (Consolidated)
For the second quarter of the fiscal year ending June 2026, net sales were JPY 109,261 million (10.6% YoY increase), operating income was JPY 5,717 million (24.4% YoY increase), and net income attributable to owners of parent was JPY 4,020 million (23.0% YoY increase).
Key Figures
- Net Sales: JPY 109,261 million (10.6% Year-over-Year increase)
- Operating Income: JPY 5,717 million (24.4% Year-over-Year increase)
- Net Income Attributable to Owners of Parent: JPY 4,020 million (23.0% Year-over-Year increase)
AI要約
Overview of Performance
For the second quarter of the fiscal year ending June 2026 (June 21, 2025 to December 20, 2025), consolidated net sales amounted to JPY 109,261 million, representing a 10.6% increase year-over-year. Operating income was JPY 5,717 million (24.4% increase YoY), ordinary income was JPY 5,843 million (23.7% increase YoY), and net income attributable to owners of parent was JPY 4,020 million (23.0% increase YoY). The number of stores totaled 499 (466 regular stores and 33 large-scale stores), with new openings and refurbishments carried out. By product category, food accounted for the largest sales, followed by sundries, cosmetics, and pharmaceuticals.
Overview of Financial Condition and Dividend
Total assets increased by JPY 7,094 million from the end of the previous consolidated fiscal year to JPY 134,420 million. Net assets rose by JPY 4,216 million to JPY 57,644 million, and the equity ratio stood at 42.8%, indicating a solid financial foundation. Cash flows from operating activities generated JPY 7,461 million, while expenditures on investing activities amounted to JPY 9,814 million. The year-end dividend is planned at JPY 6.50 per share, with an annual dividend forecast of JPY 13.00, unchanged from the previous term. The full-year earnings forecast for FY June 2026 anticipates net sales of JPY 221,200 million, operating income of JPY 11,050 million, and net income of JPY 7,850 million, expecting increases in revenue and earnings.